Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas

Moes-Sosnowska, J; Rzepecka, IK; Chodzynska, J; Dansonka-Mieszkowska, A; Szafron, LM; Balabas, A; Lotocka, R; Sobiczewski, P; Kupryjanczyk, J

Moes-Sosnowska, J (reprint author), Maria Sklodowska Curie Inst, Oncol Ctr, Dept Immunol, Roentgena 5, PL-02781 Warsaw, Poland.

CANCER BIOLOGY & THERAPY, 2019; 20 (6): 843

Abstract

Objective: DNA repair pathways are potential targets of molecular therapy in cancer patients. The FANCD2, BRIP1, BRCA1/2, and FANCF genes are involved......

Full Text Link